# Medicus Pharma Ltd. (MDCX)

> Source: Nexqual · https://nexqual.com/MDCX · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Medicus Pharma Ltd. (MDCX), nexqual.com/MDCX" · informational, not investment advice.

**Price:** USD 3.43 (+9.94% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 3.12 · day 3–3.65 · 52w 2.92–139 · market cap $4.9M · NCM

## Key facts
- Total return with dividends: 1Y -97.2% vs S&P 500 +18.1%; 5Y -96.9% vs S&P 500 +85.1%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2024-11-11) |
|---|---|---|
| Total return | -97.2% | -96.9% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -97.2% | -83.6% |
| Volatility (annualized) | 151.3% | 161.1% |
| Max drawdown | -97.7% (Oct 2025→Oct 2026) | -99.1% (May 2025→Oct 2026) |

## Peers (Drug Manufacturers - General)
OGN (Organon & Co.) USD 13.76 -0.07% · GRFS (Grifols, S.A.) USD 7.54 +5.16% · BIIB (Biogen Inc.) USD 235.35 +2.82% · SNY (Sanofi) USD 40.29 +2.99% · GSK (GSK plc) USD 49.02 +5.94% · BMY (Bristol-Myers Squibb Company) USD 60.57 +6.88%

## More
Full page: https://nexqual.com/MDCX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt